Pee Safe Secures $32 Million Series C Funding From OrbiMed
Overview
Femtech innovator Pee Safe has secured $32 million (approx. INR 288 crore) in a Series C funding round led by healthcare investor OrbiMed. The capital will drive expansion in offline retail, strengthen brand marketing, and accelerate growth across quick commerce and e-commerce marketplaces.
Funding Boost for Femtech Startup
Pee Safe announced it has successfully closed a $32 million (approximately INR 288 crore) Series C funding round. The investment was led by OrbiMed, a firm known for backing healthcare companies, and comprised a mix of primary and secondary share sales. This capital infusion signals strong investor confidence in the femtech sector.
Expansion Plans Underway
The fresh capital will be strategically deployed to expand Pee Safe's offline retail footprint significantly. The company also plans to bolster its brand-led marketing initiatives. Accelerated growth across quick commerce and leading e-commerce marketplaces is a key objective, aiming to reach a wider consumer base at scale.
Strategic Board Additions
As part of the funding agreement, OrbiMed's Dr. Sunny Sharma and Sumona Chakraborty will join Pee Safe's board of directors. Their expertise is expected to guide the company's strategic growth and market penetration efforts.
Company Background and Market Position
Founded in 2013 by Vikas Bagaria and Srijana Bagaria, Pee Safe focuses on providing affordable, body-friendly sanitary solutions for women. Co-founder Rithish Kumar joined in 2017. The startup's product range includes organic cotton tampons, intimate wash, wipes, and maternity care products. Pee Safe competes in a crowded market against brands like Sirona, Sanfe, Nua Women, and major global players such as Johnson & Johnson and Procter & Gamble.
Market Growth Trajectory
The global femtech market is expanding rapidly, valued at $60.2 billion in 2024 and projected to grow at a compound annual growth rate (CAGR) of 16% over the next decade, according to a Global Market Insights report. This growth fuels investor interest in companies like Pee Safe, addressing essential hygiene and wellness needs.
